Tuesday, June 6, 2017
- 1:45pm-3:15pm
-
Spanish Primary Familial Brain Calcification caused by SLC20A2 mutation
Genetics (Non-PD) · Exhibit Hall C
- 1:45pm-3:15pm
-
Spasmodic Dysphonia in Hereditary Spastic Paraplegia Type 7
Genetics (Non-PD) · Exhibit Hall C
- 1:45pm-3:15pm
-
Spastic paraplegia type 4: a novel SPAST splice site donor mutation and expansion of the phenotype variability
Genetics (Non-PD) · Exhibit Hall C
- 1:45pm-3:15pm
-
Spectrum of non-motor symptoms in essential tremor in a Tunisian population
Tremor · Exhibit Hall C
- 1:45pm-3:15pm
-
Spg 11 gene mutation associated autosomal recessive hereditary spastic paraplegia presenting with partially levodopa responsive parkinsonism, stereotypy and cognitive decline.
Rare Genetic and Metabolic Diseases · Exhibit Hall C
- 1:45pm-3:15pm
-
Substantia nigra hyperechogenicity in male methamphetamine users
Drug-Induced Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Successful passive monitoring of early-stage Parkinson’s disease patient mobility in Phase I RG7935/PRX002 clinical trial with smartphone sensors
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Synthesis and pharmacological evaluation of 16-aryldieno steroids as anti-parkinsonian agents in LPS induced Neuroinflammation Model of Rat
Parkinson's Disease: Pathophysiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Tacrolimus induced parkinsonism presenting as freezing of gait and speech
Drug-Induced Movement Disorders · Exhibit Hall C
- 1:45pm-3:15pm
-
Tardive Dyskinesia by Body Region in Subjects with Schizophrenia/Schizoaffective Disorder or Mood Disorder: Findings from the KINECT 3 Study
Drug-Induced Movement Disorders · Exhibit Hall C
- «Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 38
- Next Page»